Childhood refractory autoimmune haemolytic anaemia: is there a role for anti-CD20 therapy (rituximab)?
McMahon
C
C
Babu
L
L
Hodgson
A
A
Hayat
A
A
Connell
N O
NO
Smith
O P
OP
D000293:Adolescent; D000744:Anemia, Hemolytic, Autoimmune / Q000276:immunology / Q000628:therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000276:immunology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab